CN117959528A - Intelligent insulin injection management device - Google Patents
Intelligent insulin injection management device Download PDFInfo
- Publication number
- CN117959528A CN117959528A CN202410383703.0A CN202410383703A CN117959528A CN 117959528 A CN117959528 A CN 117959528A CN 202410383703 A CN202410383703 A CN 202410383703A CN 117959528 A CN117959528 A CN 117959528A
- Authority
- CN
- China
- Prior art keywords
- injection
- insulin
- card
- standard
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title claims abstract description 354
- 239000007924 injection Substances 0.000 title claims abstract description 352
- 238000002347 injection Methods 0.000 title claims abstract description 352
- 102000004877 Insulin Human genes 0.000 title claims abstract description 177
- 108090001061 Insulin Proteins 0.000 title claims abstract description 177
- 229940125396 insulin Drugs 0.000 title claims abstract description 177
- 239000012899 standard injection Substances 0.000 claims abstract description 47
- 238000001931 thermography Methods 0.000 claims abstract description 22
- 238000012545 processing Methods 0.000 claims description 17
- 238000012216 screening Methods 0.000 claims description 17
- 210000004003 subcutaneous fat Anatomy 0.000 claims description 15
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- 239000000741 silica gel Substances 0.000 claims description 8
- 229910002027 silica gel Inorganic materials 0.000 claims description 8
- 230000000007 visual effect Effects 0.000 claims description 8
- 230000035755 proliferation Effects 0.000 claims description 7
- 238000005070 sampling Methods 0.000 claims description 3
- 238000012800 visualization Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 54
- 230000008569 process Effects 0.000 abstract description 18
- 239000000463 material Substances 0.000 abstract description 4
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000001015 abdomen Anatomy 0.000 description 22
- 206010020718 hyperplasia Diseases 0.000 description 16
- 230000008859 change Effects 0.000 description 12
- 238000010586 diagram Methods 0.000 description 10
- 210000001624 hip Anatomy 0.000 description 10
- 230000035935 pregnancy Effects 0.000 description 10
- 101800001719 Albumin-1 chain b Proteins 0.000 description 9
- 210000001217 buttock Anatomy 0.000 description 7
- 238000005520 cutting process Methods 0.000 description 6
- 238000002372 labelling Methods 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 5
- 230000002159 abnormal effect Effects 0.000 description 4
- 230000006399 behavior Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000003086 colorant Substances 0.000 description 3
- 210000002414 leg Anatomy 0.000 description 3
- 210000000323 shoulder joint Anatomy 0.000 description 3
- 230000003187 abdominal effect Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000037237 body shape Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 238000010030 laminating Methods 0.000 description 2
- 238000002559 palpation Methods 0.000 description 2
- 239000013610 patient sample Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000008054 signal transmission Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 210000004394 hip joint Anatomy 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
The invention discloses an intelligent insulin injection management device, which belongs to the technical field of medical appliances, wherein the intelligent insulin injection management device comprises an insulin standard injection card, an insulin injection standard card after marking, an infrared thermal imaging scanning device, a terminal device and an intelligent table pad; the invention can effectively customize and formulate the relevant specifications of insulin injection for each patient, and one-to-one formulation of insulin injection plans is carried out; simultaneously, the selection of the materials can liberate both hands, and the injection process is safer.
Description
Technical Field
The invention relates to the technical field of medical appliances, in particular to a device for intelligently managing insulin injection.
Background
The current tool for standardized insulin injections is a set of insulin locator cards. The device comprises an abdomen positioning card, an upper arm positioning card and a leg positioning card, wherein the use mode of the device is that the positioning card is fixed at an injection position by hand, and then injection is carried out according to the positioning point of the injection card. Each point has a marked sequential number to assist the patient in insulin injection, wherein the abdomen locator card has 28 points, the upper arm locator card has 7 locating points, and the leg injection card has 14 locating points.
In the actual use process, the set of positioning card can not meet the following points:
1. Special populations include gestational patient use because it does not include areas other than around the abdomen navel, upper arm and thigh, such as: the front side in the waist and above the buttocks;
2. because the people with the extreme situation of the lack of body types in the special patients of diabetes have large individual differences of each person, the same type of sleeve card can not meet the use of the people;
3. Some patients have subcutaneous fat hyperplasia which affects insulin injection, and the current tool cannot accurately avoid the area which can not be injected in each injection process;
4. Meanwhile, the patient needs to use one hand to maintain the set of positioning card to be in an injection area all the time in the injection process, and only one hand can be used for performing injection, so that certain hidden danger exists in the injection, and if the patient needs to be matched with a kneading skin for injection, the patient cannot perform injection, so that the depth of insulin injection is insufficient, and the effect is affected;
5. In addition, for the medical staff, the area which can not be injected can not be clearly informed to the patient, and the common expressions such as the area of the left upper part of the abdomen or the area of the 3 cm around the navel are more general expressions, and when the patient is injected, the area which can not be found by the patient and the area described by the medical staff are identical, and the reason for the area with subcutaneous fat hyperplasia which is still not injectable is not well visualized and accurately transformed;
6. For whether the patient carries out good insulin injection and subcutaneous fat hyperplasia change conditions, medical staff with abundant experience can judge the hyperplasia change conditions through a palpation mode at present so as to judge the insulin injection effect of the patient, but the capacity needs long experience to support, and the specific change of the fat hyperplasia size also needs other measures to obtain accurate data.
In order to help a user to perform accurate and standardized insulin injection better, the invention designs a set of device which can help patients and medical staff to manage insulin injection intelligently.
Disclosure of Invention
Aiming at the defects existing in the prior art, the invention aims to provide an intelligent insulin injection management device, which is used for realizing automatic management of injection positions of screened patients by utilizing the intelligent insulin injection management device to intelligently identify subcutaneous fat hyperplasia and realize injection point distinguishing means, and effectively manages insulin injection by automatically customizing the arrangement of an insulin standard injection card to realize the characteristics of one person and one card.
In order to achieve the above purpose, the invention provides an intelligent insulin injection management device, which comprises an insulin standard injection card, an infrared thermal imaging scanning device, a terminal device, an intelligent table pad, an insulin injection point position identification and control accessory and an injection point use sequence visual processing matched recording device, wherein the infrared thermal imaging scanning device is used for selecting an injection region of a patient through subcutaneous fat hyperplasia region screening, the insulin injection point position identification and control accessory is used for identifying and screening color mark points of the patient and realizing injection operation after screening, the insulin standard injection card is used for sampling a patient sample, the insulin standard injection card is used for identifying and controlling the insulin standard injection card mark to form an insulin injection standard card after injection mark, and the insulin injection point use sequence visual processing matched recording device is used for recording the insulin standard injection card and the insulin injection standard card mark after injection.
Preferably, the infrared thermal imaging scanning device performs registration scanning on the injection region after fat preliminary screening, performs comparison screening after two insulin standard injection cards of the same sample are generated, and determines and selects the injection region of the patient through calculation.
Preferably, an intelligent insulin injection management device is characterized in that an information receiving module is arranged in the intelligent table pad, a plurality of injection point location areas are arranged in the intelligent table pad, the intelligent table pad receives electric signals of the type and the position of an insulin standard injection card through the information receiving module, and the intelligent table pad controls electric connection of each point location in a processing area through the electric signals.
Preferably, the device for intelligent management of insulin injection is characterized in that a plurality of injection areas are formed in the insulin standard injection card, and injection points can be marked in the injection areas.
Preferably, the insulin injection point position identification and control accessory comprises a color identification sensor and a mechanical control accessory, wherein the color identification sensor is arranged at two ends of the insulin syringe and used for identifying the color of the point position, and the mechanical control accessory is connected to the switch of the insulin syringe and used for controlling the insulin syringe to inject.
Preferably, the device of intelligent management insulin injection, the both sides of insulin standard injection card all are provided with biological silica gel, insulin standard injection card is through biological silica gel and patient's skin laminating.
Preferably, the infrared thermal imaging scanning device performs discrete degree calculation on the insulin standard injection card, and determines the proliferation state of the injection area of the patient according to the result of the discrete degree calculation.
Preferably, the device for intelligently managing insulin injection is characterized in that the injection point is identified and judged through an insulin standard injection card, an infrared thermal imaging scanning device and an intelligent table pad, and then injection is selected through an insulin injection point identification and control accessory.
Preferably, the intelligent insulin injection management device is characterized in that the injection point use sequence visualization processing matched recording device comprises an insulin standard injection card collection device and an injection point position and injection sequence identification collection bin on the insulin standard injection card.
Preferably, the device for intelligently managing insulin injection is characterized in that the injection point uses a sequence visual processing matched recording device and a collection bin arranged in the device for evaluating the actual condition of insulin injection of a patient.
In summary, the comprehensive beneficial effects of the invention are as follows:
1. The intelligent insulin injection management device can more intelligently manage the injection behaviors of patients in the insulin injection process, so that the patients can form good and standard injection habits, the probability of subcutaneous fat hyperplasia caused by improper injection is effectively avoided, the injection points are scientifically distinguished by combining an infrared thermal imaging technology, and the patients can effectively avoid non-injectable areas in the injection process;
2. The intelligent insulin injection management device can effectively help medical staff to visually present the injection behavior of a patient and the change condition of subcutaneous fat hyperplasia, and can effectively acquire whether the injection habit of the patient is good or not through the use condition of the point location in an injection area and the change condition of the position information of the point location corresponding to the subcutaneous fat hyperplasia;
3. the intelligent insulin injection management device can effectively customize and formulate relevant specifications of insulin injection of each patient, and one-to-one insulin injection plan is formulated; meanwhile, the selection of materials can release two hands, so that the injection process is safer;
4. The intelligent insulin injection management device can effectively realize full coverage of injection crowds and injection areas, realize positioning of the injection areas, enable patients to accurately find the optimal injection area range through the operation of integrating positioning points and positioning rules with medical staff, reduce the possibility of injecting the same injection point, and effectively reduce the probability of generating and deteriorating subcutaneous fat hyperplasia.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for the description of the embodiments or the prior art will be briefly described, and it is apparent that the drawings in the following description are only one embodiment of the present invention, and other drawings can be obtained according to the drawings without inventive effort for a person skilled in the art.
FIG. 1 is a schematic diagram of a usage flow in an embodiment of the present invention;
FIG. 2 is a schematic illustration of a medium and small abdominal insulin injection specification card label in an embodiment of the invention;
FIG. 3 is a schematic illustration of a medium and small abdominal insulin injection specification card label in an embodiment of the invention;
FIG. 4 is a schematic illustration of labeling of an upper arm insulin injection locator card in accordance with an embodiment of the present invention;
FIG. 5 is a schematic illustration of labeling of an upper arm insulin injection locator card in accordance with an embodiment of the present invention;
FIG. 6 is a schematic illustration of a leg insulin injection locator card labeling in an embodiment of the invention;
FIG. 7 is a schematic illustration of a leg insulin injection locator card labeling in an embodiment of the invention;
FIG. 8 is a schematic illustration of a small and medium sized waist and buttocks insulin injection locator card labeling in an embodiment of the invention;
FIG. 9 is a schematic illustration of a small and medium size waist and buttocks insulin injection locator card labeling in an embodiment of the invention;
FIG. 10 is a schematic diagram of an injection site screening process according to an embodiment of the present invention;
FIG. 11 is a schematic diagram of an image registration method according to an embodiment of the present invention;
FIG. 12 is a schematic diagram of infrared thermal imaging scanning information transmission in an embodiment of the invention;
FIG. 13 is a schematic diagram of a normalized injection method 1 according to an embodiment of the present invention;
FIG. 14 is a schematic diagram of a normalized injection method 2 according to an embodiment of the present invention;
FIG. 15 is a schematic diagram of the operation flow of the control fitting according to the embodiment of the present invention;
FIG. 16 is a schematic diagram of signal transmission according to method 2 of the embodiment of the invention;
FIG. 17 is a schematic diagram of a color gradient arrangement sequence of round cards according to an embodiment of the present invention 1;
FIG. 18 is a schematic diagram of a color gradient arrangement sequence of round cards according to an embodiment of the present invention 2;
FIG. 19 is a schematic view of a color gradient arrangement sequence of round cards according to an embodiment of the present invention; .
Detailed Description
In order to make the technical means, the creation characteristics, the achievement of the purpose and the effect of the present invention easy to understand, the technical solutions in the embodiments of the present invention are clearly and completely described below to further illustrate the present invention, and it is obvious that the described embodiments are only some embodiments of the present invention, not all versions.
The invention is described in further detail below with reference to fig. 1-19.
The invention provides a technical scheme that: the device for intelligently managing insulin injection comprises an insulin standard injection card, a marked insulin injection standard card, an infrared thermal imaging scanning device, a terminal device, an intelligent table pad, an insulin injection point position identification and control accessory, an injection point use sequence visual processing matched recording device, wherein the infrared thermal imaging scanning device is used for carrying out patient injection region selection through subcutaneous fat proliferation region screening, the insulin injection point position identification and control accessory is used for identifying and screening color marking points of patients and realizing injection operation after screening, the insulin standard injection card is used for sampling patient samples, the insulin standard injection card is used for identifying and controlling the insulin standard injection card mark to form the post-injection marked insulin injection standard card through the intelligent table pad and the terminal device, and the injection point use sequence visual processing matched recording device is used for carrying out identification recording on the insulin standard injection card and the post-injection marked insulin injection standard card mark, and specifically, the specific operation flow is as follows in combination with fig. 1:
Preparation: the device comprises 6 groups of people for selection, including children, teenagers, adults, early gestation groups, middle gestation groups and late gestation groups, wherein the standard card at each insulin injection position of each group comprises a large-size insulin standard injection card 101 and a small-size insulin standard injection card 102 which are suitable for the body shape of a diabetic patient, and the insulin injection standard card suitable for the insulin injection type at the later stage can be selected according to the body shape of each person;
The standard card comprises an abdomen insulin injection standard card a10 of children and teenagers according to injection crowd and injection parts, an upper arm insulin injection standard card b10 of the children and teenagers, and a leg insulin injection standard card c10 of the children and teenagers; adult abdomen insulin injection standard card a20, adult upper arm insulin injection standard card b20, adult leg insulin injection standard card c20; abdomen insulin injection standard card a30 for early gestation, upper arm insulin injection standard card b30 for early gestation, leg insulin injection standard card c30 for early gestation; standard card d10 for insulin injection of waist and buttocks in gestation period and middle gestation period; standard card d20 for insulin injection in the lumbar and hip of gestational period and late gestation period.
The insulin specification injection cards used by different people are distinguished by colors. For example, the adult standard cutting ferrule series is a blue cutting ferrule series, the child and teenager standard cutting ferrule series is a green cutting ferrule series, the gestation standard cutting ferrule series is a pink cutting ferrule series, and the like.
Specifically, an a-series abdomen insulin standard card injection area is divided into four areas, each area is provided with 4 rows of injection hole sites, each injection area is marked by adopting uniform colors with different transparencies, each area of each small abdomen insulin injection card surface comprises 28 injection points, and the whole card surface comprises 112 injection points; each area of each large-size injection standard card surface comprises 36 injection points, the whole card surface comprises 144 injection points, and a circular area with the center diameter of 5 cm of the card surface is a non-injection area.
As shown in fig. 2 and 3, each injection area of the small abdomen insulin injection standard card a101 has 4 rows of injection holes, a total of 4 injection areas 16 rows of injectable holes are marked with letters a-P, each row includes 7 injection points, each row is marked with 1-7 according to the W/M rotation method, each injection area of the large abdomen insulin injection standard card a102 has 4 rows of injection holes, a total of 4 injection areas 16 rows of injectable holes are marked with letters a-P, each row includes 9 injection points, each row is marked with 1-9 according to the W/M rotation method, as shown in fig. 2 and 3.
As shown in fig. 4 and 5, the injection area of the upper arm insulin injection positioning card in the b series is an area, the injection area of the small upper arm insulin injection positioning card b101 is totally 4 rows of injection holes, each row is marked by an a-D, each row comprises 5 injection points, each row is marked by 1-5 numbers according to the W/M rotation method, as shown in fig. 3, the injection area of the large upper arm insulin injection positioning card b102 is totally 6 rows of injection holes, each row is marked by an a-F, each row comprises 5 injection points, each row is marked by 1-5 numbers according to the W/M rotation method, as shown in fig. 4 and 5.
As shown in fig. 6 and 7, the injection area of the c-series leg insulin injection positioning card is an injection area, the injection area of the small-leg insulin injection standard card c101 is provided with 6 rows of injection holes, which are marked by a-F respectively, each row comprises 7 injection points, which are marked by a W/M rotation method with 1-7 numerical identifiers respectively, as shown in fig. 2, the injection area of the large-leg insulin injection standard card c102 is provided with 8 rows of injection holes, which are marked by a-H respectively, each row comprises 7 injection points, which are marked by a W/M rotation method with 1-7 seven numerical identifiers respectively, as shown in fig. 6 and 7.
As shown in fig. 8 and 9, the d series waist and hip insulin standard card injection area is divided into four areas, each area is provided with 4 rows of injection holes and each injection area is marked by different colors, each area of each small-sized abdomen insulin injection card surface comprises 28 injection points, and the whole card surface comprises 112 injection points; each area of each large injection standard card surface comprises 36 injection points, the whole card surface comprises 144 injection points, and a circular area with the center diameter of 5 cm of the card surface is a non-injection area, so that compared with the distance between the injection areas on the left side and the right side of the abdomen insulin injection standard card, the distance between the injection areas on the left side and the right side of the abdomen insulin injection standard card is much larger.
Specifically, each injection area of the injection areas of the small-sized waist and buttock insulin injection card d101 has 4 rows of injection hole sites, 4 injection area 16 rows of injectable hole sites are marked by letters A-P respectively, each row comprises 7 injection points which are marked by 1-7 according to the W/M rotation method respectively, as shown in fig. 4, each injection area of the large-sized abdomen insulin injection standard card d102 has 4 rows of injection hole sites, 4 injection area 16 rows of injectable hole sites are marked by letters A-P respectively, each row comprises 9 injection points which are marked by 1-9 according to the W/M rotation method respectively, as shown in fig. 8 and 9.
As a further embodiment of the present invention, the infrared thermal imaging scanning device performs registration scanning on the injection area after fat preliminary screening, performs comparison screening after two insulin standard injection cards of the same sample are generated, determines and selects the injection area of the patient through calculation, performs discrete degree calculation on the insulin standard injection card by the infrared thermal imaging scanning device, and determines the proliferation state of the injection area of the patient through the result of discrete degree calculation, specifically, as shown in fig. 10, the present embodiment inputs model information of the corresponding crowd and the selected insulin injection standard card into a file in the patient terminal device 30, and determines the position and the size of the area extracted by the image of the next infrared thermal imaging scanning according to the above information.
As a further embodiment of the present invention, the specific operation steps of the first to fourth steps are as follows, in conjunction with fig. 10:
The first step: the infrared thermal imaging technology is utilized to screen the existing region of subcutaneous fat hyperplasia of the patient.
The infrared thermal imaging scanning device 20 which can be connected with the mobile terminal equipment 30 (a computer, a mobile phone and the like) is utilized to scan a patient, an infrared thermal imaging image of the whole body of the patient is obtained and transmitted to the terminal equipment, and the area covered in the insulin injection position injection standard card is adjusted and taken out through an intelligent graphic registration technology according to the use position and the size model information of the insulin injection standard card of the patient recorded in the preparation work. The medical staff terminal system comprises electronic version images of insulin injection standard cards at all positions of all people, the electronic version images comprise position information of each injection point, and the two layout images are combined to ensure that the infrared thermal imaging intercepting images comprise the position information of the injection points. The following is a specific implementation process:
The position information of the injection points of the abdomen insulin injection standard card for large adults and gestational versions comprises A1-A9, B1-B9, C1-C9, D1-D9, E1-E9, F1-F9, G1-G9, H1-H9, I1-I9, J1-J9, K1-K9, L1-L9, M1-M9, N1-N9, O1-O9 and P1-P9 according to the numerical and alphabetical identification on the standard card.
The position information of the injection points of the abdomen insulin injection standard card for small adults and gestational versions comprises A1-A7, B1-B7, C1-C7, D1-D7, E1-E7, F1-F7, G1-G7, H1-H7, I1-I7, J1-J7, K1-K7, L1-L7, M1-M7, N1-N7, O1-O7 and P1-P7. The position information of the injection points of the abdomen insulin injection standard card for teenagers and children comprises A1-A5, B1-B5, C1-C5, D1-D5, E1-E5, F1-F5, G1-G5, H1-H5, I1-I5, J1-J5, K1-K5 and L1-L5.
The position information of the injection points of the abdomen insulin injection standard card for teenagers and children comprises A1-A4, B1-B4, C1-C4, D1-D4, E1-E4, F1-F4, G1-G4, H1-H4, I1-I4, J1-J4, K1-K4 and L1-L4. The position and information of the injection points of the leg insulin injection standard card for large adults and gestational versions comprise A1-A7, B1-B7, C1-C7, D1-D7, E1-E7, F1-F7, G1-G7 and H1-H7.
The position information of the injection points of the leg insulin injection standard card for small adults and gestational versions comprises A1-A7, B1-B7, C1-C7, D1-D7, E1-E7 and F1-F7.
The position information of the injection points of the upper arm insulin injection standard card of large adult and gestational version comprises A1-A5, B1-B5, C1-C5, D1-D5, E1-E5 and F1-F5. The position information of the injection points of the upper arm insulin injection standard card of the small adult and the gestational version comprises A1-A5, B1-B5, C1-C5 and D1-D5.
The variance between the temperatures is obtained by comparing the temperatures measured corresponding to adjacent injection points in the injection site, and the step of judging whether the injection area of the patient has hyperplasia or not can be realized by comparing the temperatures measured corresponding to the adjacent injection points in the injection site, wherein the variance describes the degree of dispersion of the obtained temperature values, and the larger the variance is, the more the data distribution is dispersed, so that the abnormal temperature points exist in the subcutaneous temperatures corresponding to the injection points.
If it is determined that the region is a hyperplasia, the injection points corresponding to the abnormal temperature are searched, the temperatures of all the points related to the subsequent injection points are arranged from high to low or from low to high, 10% of the maximum temperature value and 10% of the minimum temperature value are removed, the average value of the temperatures of the rest parts is calculated, the temperatures of each point are compared with the average value, the injection points with the temperature difference of more than 5% are screened and marked, the abnormal injection points are marked, and the preliminary determination is made as the non-injectable point.
As shown in fig. 11, the above-mentioned judgment result is transmitted to the terminal device of the medical staff, and the medical staff can perform the secondary judgment through skin palpation, so as to further improve the accuracy of the above-mentioned obtained non-injectable point location, and meanwhile, the terminal device can record the measurement result of the patient, so that the later-stage calling and inquiring are convenient.
As a further embodiment of the invention, an information receiving module is arranged in the intelligent table pad, a plurality of injection point location areas are arranged in the intelligent table pad, the intelligent table pad receives electric signals of the type and the position of the insulin standard injection card through the information receiving module, and the intelligent table pad controls the electric connection of each point location in the processing area through the electric signals.
And a second step of: the position information of the non-injectable point marked by the first step screening and the model information of the insulin injection specification card to be used by the patient later are transmitted to the intelligent table pad 40 through bluetooth or connection.
The surface of the intelligent table pad 40 is divided into four large areas, namely an abdomen insulin injection point processing area a40, an upper arm insulin injection point processing area b40, a leg insulin injection point processing area c40 and a special injection point processing area d40 for pregnant women.
The intelligent table pad 40 is provided with information receiving modules 401a and 401, the main functions of the intelligent table pad 40 are receiving signals of standard card type information and position information, the standard card type identification can help the intelligent table pad to confirm and select an area to be heated in four large areas, the intelligent table pad 40 is simultaneously provided with a processor 401b which is connected with all injection points on the table pad through a circuit, the circuit of the point at the corresponding position of the table pad is controlled to be connected through receiving the signals of the position information of the non-injection points transmitted by a host end, the heating device 402 is normally used, the effect of heating the point is achieved by electrifying, the power-off state is kept without transmitting the position information of the point, the heating condition of the heating device 402 of the corresponding point on the table pad is firstly preheated for 3 seconds, and then medical staff heats the table pad to 65 degrees in 10 seconds and maintains 10 seconds to be automatically closed by pressing a start heating key on the intelligent table pad 40.
As a further embodiment of the present invention, the third step: medical staff places the insulin injection standard card which is to be used by a patient subsequently in the corresponding area of the intelligent table pad 40 to carry out color change treatment on injection points, because irreversible thermochromic paint is coated above all the injection points on the standard card, when the temperature is heated to 65 ℃, the color of the original injection point can be changed and the color can not be changed after the temperature is reduced, and the visible respectively of the injectable points and the non-injectable points on the standard card is realized through the above actions.
Note that: the first to third step information transmission flows described above are shown in fig. 12.
As a further embodiment of the present invention, the fourth step: the marked insulin injection specification card 110 is given to the patient, the patient is informed of the insulin rotation injection method, and the special color point is definitely the non-injectable point and the injection is not needed. The alternating injection method of the insulin standard injection card comprises the following steps:
1. Insulin injection standard card for two injection areas above the waist and buttocks of special abdomen and gestational group:
① The priority of the major rotations of the injection areas in the standard card can be judged according to letters: the corresponding region of letters A-D is a first priority; the corresponding region of the letter E-H is of a second priority; the corresponding region of the letter I-L is of a third priority; the corresponding region of letter M-P is of fourth priority.
② The small rotations within each injection zone are then distinguished by a numerical identification. Here, unlike other insulin assisted injection tools, are: the smallest number within the injection area is always preferred as the starting injection point during the injection process.
For example: when four numbers 1,2,3 and 4 are simultaneously present in A, B, C, D columns, all the injection points with the number 1 in the four columns are preferably selected for injection, when all the injection points with the number 1 are used, three numbers 2,3 and 4 are present in A, B, C, D columns, and all the injection points with the number 2 are preferably selected for injection. Similarly, until all the injection points with the number of 4 in the four columns are used, compared with the traditional insulin injection rule, the rotation mode has the advantages that firstly, the distance between the points is larger and more distant, and the probability of subcutaneous fat hyperplasia in the repeated insulin injection process is effectively reduced.
And secondly, the non-linear injection habit of the W/M rotation injection method in the insulin injection rotation rule is adopted, so that the insulin injection rotation method is more scientific.
Specifically, the fifth step: the biological silica gel that both sides of insulin injection standard card had utilizes biological silica gel to tear the film and the laminating of skin on both sides after fixing the position according to the setpoint, and wherein carry out standardized injection method has 3 kinds, do respectively:
Method 1: as shown in figure 13, the patient can select the injection points of the injectable with the digital marks which are correctly rotated to inject insulin after fitting. The round material covered on the injection point is firstly deducted before injection, and the skin of the injection point is exposed through the clamping surface.
As a further embodiment of the invention, the hands of the patient can be liberated by the application of the bio-silica gel material to perform actions such as skin pinching injection, wherein the service life of the bio-silica gel is 6 years, and the adhesiveness between the patient and the skin can be ensured in the service period of the patient.
As a further embodiment of the invention, the specific positioning points and positioning methods of the injection specification card are as follows:
a. The positioning points of the standard injection cards of the injection areas on the two sides of the abdomen and the waist and the outer upper part of the buttocks are navel, and the standard injection cards are directly attached after the positioning is finished;
b. the positioning point of the standard injection card of the upper arm injection area is a shoulder joint, and is matched with a positioning ruler with 1 cm as an interval to assist in positioning;
The positioning method comprises the following steps:
① The medical staff places the clamping surface in a proper injection area of a patient, extends the positioning ruler to a shoulder joint positioning point, and determines the distance between the injection area and the positioning point;
② The specific location of the injection area is determined and marks are made on the positioning ruler. Thereby helping the patient to find the corresponding injection region in the subsequent injection behavior;
The patient only needs to attach the position marked on the positioning ruler by medical staff to the shoulder joint in the subsequent injection process, extends to the injection area, and finally stops at the optimal injection area;
C. the positioning point of the standard injection card of the leg injection area is the hip joint, and the positioning is assisted by matching with a positioning ruler with 1 cm as the interval. The positioning method is the same as that of the upper arm standard injection card, and the positioning points are replaced.
As a further embodiment of the invention, method 2: to assist the patient in performing more regular and more rigorous insulin injections during this step, the present device also provides insulin injection site identification and control fittings for the insulin syringe as shown in fig. 14. The operation flow of the fitting is shown in fig. 15.
The fitting consists of two parts:
a. The color identification sensor is connected to the injection end of the injector and is used for identifying whether the color of the point location is the color of the injectable point location or not;
b. and the mechanical control accessory is connected to the injection switch of the injector and is used for judging whether to unlock the injection switch according to the information identified by the color sensor.
The sensor can record the color of the injectable point in advance, and the consistency of the color recorded is judged by comparing the color of the identification point and the 0.5 millimeter surrounding the point with the recorded color. The color recognition sensor will select whether to transmit a signal to a mechanical control fitting located at the injection switch: if the color judgment is consistent, the sensor transmits a signal to a signal receiver of the mechanical part, the signal receiver receives the signal, the mechanical part is unlocked, and the injector can be normally used for injection; if the color judgment is inconsistent, the color recognition sensor does not transmit a signal, the mechanical control part does not unlock after receiving the signal, and the insulin syringe switch cannot be used normally so as to prevent the injection behavior of the patient.
The signal transmission of the above method 2 is shown in fig. 16.
As a further embodiment of the invention, method 3: in order to help medical staff to clearly define the rotation condition of the injection points of a patient in the injection process, a set of matched recording device which can visualize the use sequence of all the injection points used in the injection process is added into the system.
The device has the main functions that deducted round cards of each injection point position of a patient are sequentially collected into a collection bin in the device according to the sequence, the color of the round cards in the collection bin and the gradual change arrangement sequence of the color can reflect the actual injection sequence of the patient in the injection process, the patient brings the device back to a hospital after the injection period is finished, and medical staff judges through observing the round cards in the collection bin of the device: firstly, whether a card representing the color of an injection-free point is in the device or not, and then whether the gradual change of the color of the card is disordered or not is observed, 3 conditions can be shown in a collecting bin in the recording device:
Case 1: as shown in fig. 17, if a circular card representing the color of the non-injectable spot exists therein, this represents that the patient has a wrong choice of injection spot during the injection process;
Case 2: as shown in fig. 18, if there is no wrong color but the color is graded as not smooth or confusing, this represents that the patient does not perform the injection in the correct rotation injection method during the injection;
Case 3: as shown in fig. 19, if the color of the round card in the bin is not abnormal, the gradual change is correct and orderly, which represents that the alternate injection habit of the patient in the injection process is good, and all the above three conditions can be used as one of conditions for medical staff to judge the subcutaneous fat hyperplasia change condition of the injection area of the patient.
Among the 3 standardized injection methods provided above, method 1 is faster and simpler than the other two methods, but cannot monitor the rotation sequence and avoid the point positions of the non-injectable area. Compared with the method 1, the method 2 can avoid the non-injectable area forcefully, but cannot monitor the rotation sequence in the method 3, so that any one of the three methods can be selected for use by a patient in actual practice, or the method 1 and the method 3 can be selected for use or the method 2 and the method 3 can be used in combination.
Specifically, the sixth step: by means of the insulin injection standard card rotation sequence recording device brought back to the hospital by the patient and the insulin injection standard card which has been used for a certain period, the medical staff can evaluate the injection standard condition of the patient in the injection period.
Specifically, the seventh step: if the patient needs to continue insulin injection subsequently, repeating two to five steps to reform an insulin injection standard card with point location distinction for the patient according to the latest subcutaneous fat proliferation change condition and point location information change condition, and injecting according to the updated injection standard subsequently. The position information changes of all the points are synchronized into the file in the patient terminal system 30 to form relevant information of the subendothelial fat proliferation changes of the patient injection site in the insulin injection process, and the relevant information can be provided for comparison and check later.
The present embodiment is only for explanation of the present invention and is not to be construed as limiting the present invention, and modifications to the present embodiment, which may not creatively contribute to the present invention as required by those skilled in the art after reading the present specification, are all protected by patent laws within the scope of claims of the present invention.
Claims (10)
1. The device comprises an insulin standard injection card, an infrared thermal imaging scanning device, a terminal device, an intelligent table pad, an insulin injection point position identification and control accessory and an injection point use sequence visual processing matched recording device, wherein the infrared thermal imaging scanning device is used for carrying out patient injection region selection through subcutaneous fat proliferation existing region screening, the insulin injection point position identification and control accessory is used for identifying and screening color mark points of patients and realizing injection operation after screening, the insulin standard injection card is used for sampling patient specimens, the insulin standard injection card mark is used for identifying and controlling the insulin standard injection card mark to form an insulin injection standard card after injection mark, and the injection point use sequence visual processing matched recording device is used for carrying out insulin standard injection card and insulin injection standard card mark record after injection mark.
2. The device for intelligently managing insulin injections according to claim 1, wherein: the infrared thermal imaging scanning device performs registration scanning on the injection region after fat preliminary screening, performs comparison screening after two insulin standard injection cards of the same sample are generated, and determines and selects the injection region of a patient through calculation.
3. The device for intelligently managing insulin injections according to claim 1, wherein: the intelligent table pad is internally provided with an information receiving module, the intelligent table pad is internally provided with a plurality of injection point location areas, the intelligent table pad receives electric signals of the type and the position of the insulin standard injection card through the information receiving module, and the intelligent table pad controls the electric connection of each point location in the processing area through the electric signals.
4. The device for intelligently managing insulin injections according to claim 1, wherein: the inside of insulin standard injection card has offered a plurality of injection region, can annotate injection point in the injection region.
5. The device for intelligently managing insulin injections according to claim 1, wherein: the insulin injection point position identification and control accessory comprises a color identification sensor and a mechanical control accessory, wherein the color identification sensor is arranged at two ends of the insulin syringe and used for identifying the color of the point position, and the mechanical control accessory is connected to the switch of the insulin syringe and used for controlling the insulin syringe to inject.
6. The device for intelligently managing insulin injections according to claim 4, wherein: both sides of the insulin standard injection card are provided with biological silica gel, and the insulin standard injection card is attached to the skin of a patient through the biological silica gel.
7. The device for intelligently managing insulin injections according to claim 2, wherein: the infrared thermal imaging scanning device performs discrete degree calculation on the insulin standard injection card, and judges the proliferation state of the injection region of the patient according to the result of the discrete degree calculation.
8. The device for intelligently managing insulin injections according to claim 4, wherein: and after the injection point is identified and judged by the insulin standard injection card, the infrared thermal imaging scanning device and the intelligent table pad, the injection is selected by the insulin injection point identification and control accessory.
9. The device for intelligently managing insulin injections according to claim 1, wherein: the matched recording device for the visual processing of the injection point use sequence comprises an insulin standard injection card collection bin for identifying injection points and injection sequences on the insulin standard injection card.
10. The device for intelligently managing insulin injections according to claim 9, wherein: the injection point using sequence visualization processing matched recording device and a collection bin arranged in the same are used for evaluating the actual condition of insulin injection of a patient.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410383703.0A CN117959528B (en) | 2024-04-01 | Intelligent insulin injection management device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410383703.0A CN117959528B (en) | 2024-04-01 | Intelligent insulin injection management device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN117959528A true CN117959528A (en) | 2024-05-03 |
| CN117959528B CN117959528B (en) | 2024-07-02 |
Family
ID=
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110288527A1 (en) * | 2008-11-07 | 2011-11-24 | Benny Pesach | Device and method for drug delivery |
| CN206295489U (en) * | 2013-12-04 | 2017-07-04 | 贝克顿·迪金森公司 | System for prompting for changing the position of injection site |
| US20180133411A1 (en) * | 2016-11-14 | 2018-05-17 | Xiang Yu | Systems and Methods for Detecting and Visualizing Blood Vessels |
| CN112156283A (en) * | 2020-09-28 | 2021-01-01 | 上海中冶医院 | Insulin injection abdomen dial plate positioning device and using method |
| CN213100087U (en) * | 2020-05-04 | 2021-05-04 | 东莞市厚街医院 | Insulin subcutaneous injection region rotation prompt card |
| CN113209424A (en) * | 2021-05-17 | 2021-08-06 | 嘉兴市第一医院 | Intelligent multifunctional box for accurately positioning insulin injection and control system thereof |
| US20220379018A1 (en) * | 2019-12-10 | 2022-12-01 | Neodyne Biosciences, Inc. | Tensioned infusion systems with removable hubs |
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110288527A1 (en) * | 2008-11-07 | 2011-11-24 | Benny Pesach | Device and method for drug delivery |
| CN206295489U (en) * | 2013-12-04 | 2017-07-04 | 贝克顿·迪金森公司 | System for prompting for changing the position of injection site |
| US20180133411A1 (en) * | 2016-11-14 | 2018-05-17 | Xiang Yu | Systems and Methods for Detecting and Visualizing Blood Vessels |
| US20220379018A1 (en) * | 2019-12-10 | 2022-12-01 | Neodyne Biosciences, Inc. | Tensioned infusion systems with removable hubs |
| CN213100087U (en) * | 2020-05-04 | 2021-05-04 | 东莞市厚街医院 | Insulin subcutaneous injection region rotation prompt card |
| CN112156283A (en) * | 2020-09-28 | 2021-01-01 | 上海中冶医院 | Insulin injection abdomen dial plate positioning device and using method |
| CN113209424A (en) * | 2021-05-17 | 2021-08-06 | 嘉兴市第一医院 | Intelligent multifunctional box for accurately positioning insulin injection and control system thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20110124996A1 (en) | Diabetes health management systems and methods | |
| CN105142518A (en) | Diabetes management system with time keeping | |
| CN104619238A (en) | Biological information processing system, biological information measurement device, control device, method for controlling these, and storage medium | |
| CN110010247A (en) | A kind of personalized physical health based terminal system based on artificial intelligence | |
| CN108334731A (en) | Chronic diseases management system and method based on health examination all-in-one machine | |
| CN107993538A (en) | Electric circuit inspection maintenance skills training and examination system | |
| CN117959528B (en) | Intelligent insulin injection management device | |
| CN109620124A (en) | A kind of campus vision monitoring system | |
| CN117959528A (en) | Intelligent insulin injection management device | |
| CN110393503A (en) | Vision inspection system with cloud service function | |
| WO2006023534A2 (en) | Medical timing apparatus and method for use during pregnancy | |
| CN110381832A (en) | Urination information display device and urination information display system | |
| CN104905762A (en) | Automatic vision detection device | |
| CN105373991A (en) | Early warning system and early warning method based on MEWS mechanism | |
| CN210170027U (en) | Unattended vision detection system | |
| CN110115571A (en) | Wireless sign monitoring device and its wireless connecting establishment method | |
| CN115410678A (en) | Intelligent visual wrist strap for recording emergency chest pain patient rescue time and control system | |
| CN113884172A (en) | Intelligent height and weight measuring system for infants | |
| CA2912162A1 (en) | Method and apparatus for characteristic monitoring in conjunction with a mode of continuously measured blood glucose values and computer program product | |
| CN108831566A (en) | A kind of diabetes comprehensive intelligent medical platform based on intelligent terminal | |
| JP4608053B2 (en) | Medical pump monitor system capable of displaying infusion circuit diagram, control method thereof, and computer-readable memory | |
| CN113241145A (en) | Perioperative period big data-based operation and anesthesia quality assessment and guidance system | |
| Shabot et al. | An automatic PDMS interface for the Urotrack Plus 220 urimeter | |
| TWM632929U (en) | indoor positioning system | |
| CN219895765U (en) | Synchronous acquisition device for near-infrared brain function signals and surface electromyographic signals |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant |